FAKTOR OPTIONSSCHEIN - BOSTON SCIENTIFIC | Market Closed - Börse Stuttgart 03:58:21 2024-07-05 pm EDT | ||
| 63.71 EUR | -0.59% |
|
| Current month | -10.25% | ||
| 1 month | -2.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 63.71 | -0.59% |
| 24-07-04 | 64.09 | -3.90% |
| 24-07-03 | 66.69 | +5.09% |
| 24-07-02 | 63.46 | -12.78% |
| 24-07-01 | 72.76 | +2.49% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 03:58 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | Goldman Sachs |
| WKN | GK6YHK |
| ISIN | DE000GK6YHK0 |
| Date issued | 2022-06-28 |
| Strike | 68.5 $ |
| Maturity | Unlimited |
| Parity | 0.12 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 82.6 € |
|---|---|
| Lowest since issue | 3.07 € |
| Spread | 2 € |
| Spread % | 3.07% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.4
USD
Average target price
82.71
USD
Spread / Average Target
+8.27%
- Stock Market
- Certificates
- Certificat
